These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19323785)

  • 21. Tumours of the liver.
    Frith CH; Ward JM; Turusov VS
    IARC Sci Publ; 1994; (111):223-69. PubMed ID: 8082908
    [No Abstract]   [Full Text] [Related]  

  • 22. Report of a workshop on classification of specific hepatocellular lesions in rats.
    Squire RA; Levitt MH
    Cancer Res; 1975 Nov; 35(11 Pt 1):3214-23. PubMed ID: 171067
    [No Abstract]   [Full Text] [Related]  

  • 23. Chronic care and monitoring of woodchucks (Marmota monax) during repeated magnetic resonance imaging of the liver.
    McKenzie EJ; Jackson M; Turner A; Gregorash L; Harapiak L
    J Am Assoc Lab Anim Sci; 2006 Mar; 45(2):26-30. PubMed ID: 16542039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant transformation of hepatocellular adenoma: report of a case.
    Mouhoub M; Miry A; Haloui A; Karich N; Kamaoui I; Soufi M; Bennani A
    Pan Afr Med J; 2020; 35():92. PubMed ID: 32636990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staging for hepatocellular carcinoma: look for a perfect classification system.
    Huo TI; Lee SD; Wu JC
    J Hepatol; 2004 Jun; 40(6):1041-2; author reply 1042-3. PubMed ID: 15158351
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatocellular adenoma as a risk factor for hepatocellular carcinoma in a non-cirrhotic liver: a plea against.
    Witjes CD; Ten Kate FJ; van Aalten SM; Dwarkasing RS; Willemssen FE; Verhoef C; de Man RA; Ijzermans JN
    Gut; 2012 Nov; 61(11):1645-6. PubMed ID: 22535376
    [No Abstract]   [Full Text] [Related]  

  • 27. Genetics and imaging of hepatocellular adenomas: 2011 update.
    Katabathina VS; Menias CO; Shanbhogue AK; Jagirdar J; Paspulati RM; Prasad SR
    Radiographics; 2011 Oct; 31(6):1529-43. PubMed ID: 21997980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver cell adenoma with concomitant hepatocellular carcinoma: report of two cases.
    Chuang WY; Chen TC; Hsu HL; Lee WC; Jeng LB; Huang SF
    J Formos Med Assoc; 2002 Nov; 101(11):798-802. PubMed ID: 12517062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subclassification of hepatocellular adenomas: practical considerations in the implementation of the Bordeaux criteria.
    Miller GC; Campbell CM; Manoharan B; Bryant R; Cavallucci D; O'Rourke N; Clouston AD
    Pathology; 2018 Oct; 50(6):593-599. PubMed ID: 30149989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes.
    Bioulac-Sage P; Sempoux C; Frulio N; Le Bail B; Blanc JF; Castain C; Laurent C; Trillaud H; Chiche L; Balabaud C
    Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):12-19. PubMed ID: 30213653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatocellular carcinoma of specific developmental type (massive type, pedunculated type, extrahepatic type, diffuse type, and intra-bile duct developmental type)].
    Nakanishi T; Kitamoto M; Kajiyama G
    Ryoikibetsu Shokogun Shirizu; 1995; (7):495-7. PubMed ID: 8749535
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatocellular carcinoma in a liver-cell adenoma within a non-cirrhotic liver.
    Burri E; Steuerwald M; Cathomas G; Mentha G; Majno P; Rubbia-Brandt L; Meier R
    Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):437-41. PubMed ID: 16538118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatic tumors resembling hepatocellular carcinoma].
    Kojiro M
    Ryoikibetsu Shokogun Shirizu; 1995; (7):374-7. PubMed ID: 8749499
    [No Abstract]   [Full Text] [Related]  

  • 34. MR features of inflammatory hepatic adenoma.
    Abir A; Cazejust J; Arrivé L; Menu Y
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):109-10. PubMed ID: 23273497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Regulations in the classification of primary liver neoplasms].
    Kasai Y; Sugahara K
    Nihon Rinsho; 1982; 40(1):15-25. PubMed ID: 6283200
    [No Abstract]   [Full Text] [Related]  

  • 36. What's in a name?
    Bioulac-Sage P; Balabaud C; Zucman-Rossi J
    Hepatology; 2010 Mar; 51(3):1086-7. PubMed ID: 20198625
    [No Abstract]   [Full Text] [Related]  

  • 37. Case 23-2005: a man with a mass in the liver.
    Smith AD; Morse MA; Kuo PC
    N Engl J Med; 2005 Nov; 353(20):2195-7; author reply 2195-7. PubMed ID: 16299939
    [No Abstract]   [Full Text] [Related]  

  • 38. Staging systems for hepatocellular carcinoma: should we all use the BCLC system?
    Marrero JA
    J Hepatol; 2006 Apr; 44(4):630-2. PubMed ID: 16503077
    [No Abstract]   [Full Text] [Related]  

  • 39. Is the search for a single comprehensive staging system for hepatocellular carcinoma an elusive one?
    McClune AC; Tong MJ
    J Clin Gastroenterol; 2009 Sep; 43(8):697-8. PubMed ID: 19636257
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatocellular adenoma: Classification, variants and clinical relevance.
    Bioulac-Sage P; Sempoux C; Balabaud C
    Semin Diagn Pathol; 2017 Mar; 34(2):112-125. PubMed ID: 28131467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.